Monthly Archives: January 2016
Organoid Models of Human Gastrointestinal Development and Disease
We have greatly advanced our ability to grow a diverse range of tissue-derived and pluripotent stem cell-derived gastrointestinal (GI) tissues in vitro. These systems, broadly referred to as organoids, have allowed the field to move away from the often… Continue reading
Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Evidence-based management of patients with hepatocellular carcinoma (HCC) is key to their optimal care. For individuals at risk for HCC, surveillance usually involves ultrasonography (there is controversy over use of biomarkers). A diagnosis of HCC is made based on findings from biopsy or imaging analyses. Molecular markers are not used in diagnosis or determination of prognosis and treatment for patients. The Barcelona Clinic Liver Cancer algorithm is the most widely used staging system. Patients with single liver tumors or as many as 3 nodules <3 cm are classified as having very early or early-stage cancer, and benefit from resection, transplantation, or ablation. Continue reading
Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Evidence-based management of patients with hepatocellular carcinoma (HCC) is key to their optimal care. For individuals at risk for HCC, surveillance usually involves ultrasonography (there is controversy over use of biomarkers). A diagnosis of HCC is made based on findings from biopsy or imaging analyses. Molecular markers are not used in diagnosis or determination of prognosis and treatment for patients. The Barcelona Clinic Liver Cancer algorithm is the most widely used staging system. Patients with single liver tumors or as many as 3 nodules <3 cm are classified as having very early or early-stage cancer, and benefit from resection, transplantation, or ablation. Continue reading
How safe is Moderate Alcohol Consumption in Overweight and Obese Individuals?
How safe is Moderate Alcohol Consumption in Overweight and Obese Individuals?
Rectal Indomethacin Does not Prevent Post-ERCP Pancreatitis in Consecutive Patients
Rectal indomethacin, a non-steroidal anti-inflammatory drug, is given to prevent pancreatitis in high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), based on findings from clinical trials. European Society for Gastroint… Continue reading
Rectal Indomethacin Does not Prevent Post-ERCP Pancreatitis in Consecutive Patients
Rectal indomethacin, a non-steroidal anti-inflammatory drug, is given to prevent pancreatitis in high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), based on findings from clinical trials. European Society for Gastroint… Continue reading
Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: a Population-based Cohort Study
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors), commonly prescribed to prevent cardiovascular disease, promote apoptosis and limit proliferation of esophageal cancer cell lines. We investigated whether statin use following diagnos… Continue reading
Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: a Population-based Cohort Study
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors), commonly prescribed to prevent cardiovascular disease, promote apoptosis and limit proliferation of esophageal cancer cell lines. We investigated whether statin use following diagnos… Continue reading